Skip to main content
HURA
NASDAQ Life Sciences

TuHURA 10-Q: $1.9M Cash, $18.1M Nine-Month Burn, 49.2M Dilutive Shares Outstanding

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.43
Mkt Cap
$92.404M
52W Low
$0.41
52W High
$3.43
52W Position info
249% above low
Off High info
58% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

HURA has more than doubled off its 52-week low of $0.41 on elevated volume (2.2× avg).

Summary

TuHURA's Q3 10-Q shows $1.9 million of cash against $18.1 million of nine-month operating burn, funded by $9.2 million drawn on its related-party Parkview revolver and $8.3 million of equity sales. The company says it is funded into 2028, but 49.2 million dilutive options and warrants overhang the 65.8 million shares outstanding.


Key Events · Earnings and Guidance · HURA

  • Q3 Net Loss $23.2M, Cash Down to $1.9M

    Nine-month net loss of $23.2 million versus $23.3 million a year earlier; cash and equivalents fell to $1.9 million at September 30, 2026 from $3.6 million at December 31, 2025.

  • Burn Funded by Revolver and Stock Sales

    Operating cash burn of $18.1 million was covered by $16.5 million of financing inflows: $9.2 million drawn on the Parkview facility and $8.3 million of common stock proceeds, including $0.8 million from the ATM.

  • Parkview Facility Terms: 12%, Royalty, Share Fee

    The $50 million related-party revolver matures April 21, 2031, bears 12% interest (18% on default), carries a $5 million commitment fee paid in 1,878,287 shares, a 1.5% annual facility fee, and a low-to-mid-single-digit royalty on IFx-2.0 net sales up to $450 million per year.

  • Post-Quarter Borrowings Reach $14.2M Total

    TuHURA borrowed an additional $4.95 million under the Parkview facility after September 30, 2026, bringing total borrowings to approximately $14.2 million since inception.


Analysis · HURA · Life Sciences

The headline numbers were already out in this morning's 8-K, but the 10-Q fills in what actually matters for survival: $1.9 million of cash at September 30 against $18.1 million of operating cash burn over nine months, with the gap plugged by $9.2 million drawn on the Parkview revolver and $8.3 million of stock sales. The revolver is the lifeline — a $50 million facility from a related party (Vijay Patel's Parkview) at 12% interest, sweetened with a $5 million commitment fee paid in 1,878,287 shares and a low-to-mid-single-digit royalty on IFx-2.0 sales up to $450 million a year. Management says existing resources fund operations into 2028, but that assumes continued drawdowns. The dilution stack is the other story: 17.2 million options and 32.0 million warrants sit against 65.8 million shares outstanding, so any sustained move above the $1.95–$2.99 strike band brings a wave of new supply.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HURA was trading at $1.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $92.4M. The 52-week trading range was $0.41 to $3.43. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HURA - Latest Insights

HURA
Oct 05, 2026, 7:45 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.94
Real-time Price: $1.43 info
Change: -$0.510 (-26%) info
Market Cap: $92.404M info
HURA
Sep 14, 2026, 7:45 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $2.05
Real-time Price: $1.43 info
Change: -$0.620 (-30%) info
Market Cap: $92.404M info
HURA
Aug 14, 2026, 8:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.43 info
Change: -$0.870 (-38%) info
Market Cap: $92.404M info
HURA
Aug 14, 2026, 7:45 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.30
Real-time Price: $1.43 info
Change: -$0.870 (-38%) info
Market Cap: $92.404M info
HURA
Jul 09, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.34
Real-time Price: $1.43 info
Change: -$0.910 (-39%) info
Market Cap: $92.404M info